Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.

Effect of Obesity on Prostate-Specific Antigen, Prostate Volume, and International Prostate Symptom Score in Patients with Benign Prostatic Hyperplasia

´ëÇѺñ´¢±â°úÇÐȸÁö 2011³â 52±Ç 6È£ p.401 ~ 405
±èÁ¾¹Î, ¼ÛÇÊÇö, ±èÇöÅÂ, ¹®±âÇÐ,
¼Ò¼Ó »ó¼¼Á¤º¸
±èÁ¾¹Î ( Kim Jong-Min ) 
Yeungnam University College of Medicine Department of Urology

¼ÛÇÊÇö ( Song Phil-Hyun ) 
Yeungnam University College of Medicine Department of Urology
±èÇöÅ ( Kim Hyun-Tae ) 
Yeungnam University College of Medicine Department of Urology
¹®±âÇР( Moon Ki-Hak ) 
Yeungnam University College of Medicine Department of Urology

Abstract


Purpose: We examined the correlation between body mass index (BMI) as a marker of obesity and prostate-specific antigen (PSA), prostate volume (PV), and International Prostate Symptom Score (IPSS) in patients with benign prostatic hyperplasia (BPH).

Materials and Methods: From January 2008 to December 2008, we examined 258 patients diagnosed with BPH. Patients taking 5¥á-reductase inhibitors or those diagnosed with prostate cancer were excluded from this study. BPH was defined as PV¡Ã25 ml and IPSS¡Ã8. BMI (kg/m2) was categorized into 4 groups as follows: BMI<18.5 (underweight), BMI 18.5-23.0 (normal), BMI 23.0-27.5 (overweight), and BMI>27.5 (obese). The relationships between PSA, PV, IPSS, and BMI were analyzed by correlation analysis and one-way ANOVA.

Results: The mean age of the patients was 65.19¡¾9.13 years and their mean BMI was 23.7¡¾4.4 kg/m2. The mean PSA values of each BMI group were as follows: 3.42¡¾1.53, 3.07¡¾1.88, 2.74¡¾1.75, and 2.60¡¾1.44 ng/ml. The PSA value was lowest in the obese group. The correlation analysis showed a negative correlation between BMI and PSA (Pearson¡¯s correlation coefficient=-0.142, p=0.023) and positive correlations between BMI and PV (Pearson¡¯s correlation coefficient=0.32, p=0.001) and IPSS (Pearson¡¯s correlation coefficient=0.470, p=0.02). These correlations were also confirmed by one-way ANOVA.

Conclusions: Patients with an elevated BMI tended to have lower PSA values, larger PVs, and a higher IPSS. We suggest that weight loss could be helpful for BPH symptom relief as well as for detection of coexisting prostate cancer in BPH patients.

Å°¿öµå

Analysis of variance; Body mass index; Prostatic hyperplasia

¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸

   

µîÀçÀú³Î Á¤º¸

KCI
KoreaMed
KAMS